uniQure (QURE) Net Cash Flow (2016 - 2026)
uniQure (QURE) recorded quarterly Net Cash Flow of $60.9 million in Q1 2026, up 111.78% quarter-over-quarter from -$516.5 million in Q4 2025, and up 7.41% on a YoY basis from $56.7 million in Q1 2025.
uniQure (QURE) Net Cash Flow (2016 - 2026) Analysis & Trends
uniQure's Net Cash Flow history runs 11 years deep, the most recent figure standing at $60.9 million for Q1 2026.
- In Q1 2026, Net Cash Flow rose 7.41% year-over-year to $60.9 million; the TTM figure through Mar 2026 stood at -$80.0 million (down 207.2% YoY), while the FY2025 annual figure was -$84.2 million, down 6.23% from the prior year.
- Net Cash Flow was $60.9 million for Q1 2026 at uniQure, up from -$516.5 million in the prior quarter.
- In the past five years, Net Cash Flow ranged from a high of $359.0 million in Q2 2023 to a low of -$516.5 million in Q4 2025.
- Historically, Net Cash Flow has averaged -$24.6 million across 5 years, with a median of -$20.2 million in 2022.
- The sharpest annual moves came in 2022 and 2023: Net Cash Flow sank 971.33% in 2022, then surged 1877.17% in 2023.
- A 5-year view of Net Cash Flow shows it stood at -$222.3 million in 2022, then surged by 104.53% to $10.1 million in 2023, then tumbled by 954.13% to -$86.0 million in 2024, then tumbled by 500.67% to -$516.5 million in 2025, then jumped by 111.78% to $60.9 million in 2026.
- The last three Net Cash Flow figures came in at $60.9 million (Q1 2026), -$516.5 million (Q4 2025), and $342.4 million (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Cash Flow (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 925,601.88 Bn | 925,601.85 Bn | - | - |
| 2 | Belite Bio | 58,560.00 Bn | 58,560.00 Bn | - | - |
| 3 | Quantum Biopharma | 17,284.41 Bn | 17,284.40 Bn | - | 2.44 Mn |
| 4 | Legend Biotech | 2,809.00 Bn | 2,808.71 Bn | 242.10 Mn | 625.70 Mn |
| 5 | Evaxion A | 1,334.43 Bn | 1,334.42 Bn | - | - |
| 6 | Akari Therapeutics | 1,312.27 Bn | 1,312.26 Bn | - | -2.44 Mn |
| 7 | Psyence Biomedical | 212.16 Bn | 212.16 Bn | - | - |
| 8 | Vertex Pharmaceuticals | 114.83 Bn | 107.58 Bn | 2.59 Bn | 457.40 Mn |
| 9 | Abivax | 91.96 Bn | 91.96 Bn | - | 664,983.53 |
| 10 | uniQure | 2.88 Bn | 2.88 Bn | 3.34 Mn | 60.87 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 60.87 Mn |
| Mar 31, 2026 | 60.87 Mn |
| Dec 31, 2025 | -516.49 Mn |
| Dec 31, 2025 | -516.49 Mn |
| Sep 30, 2025 | 342.42 Mn |
| Sep 30, 2025 | 342.42 Mn |
| Jun 30, 2025 | 33.22 Mn |
| Jun 30, 2025 | 33.22 Mn |
| Mar 31, 2025 | 56.67 Mn |
| Mar 31, 2025 | 56.67 Mn |
| Dec 31, 2024 | -85.99 Mn |
| Dec 31, 2024 | -85.99 Mn |
| Sep 30, 2024 | -41.95 Mn |
| Sep 30, 2024 | -41.95 Mn |
| Jun 30, 2024 | 45.23 Mn |
| Jun 30, 2024 | 45.23 Mn |
| Mar 31, 2024 | 3.41 Mn |
| Mar 31, 2024 | 3.41 Mn |
| Dec 31, 2023 | 10.07 Mn |
| Dec 31, 2023 | 10.07 Mn |